Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Novartis Drug Discovery Centralization Brings R&D Relocations, Job Cuts

Executive Summary

Novartis' efforts to rationalize and centralize its drug discovery programs will see the Novartis Institute for Tropical Diseases moved from Singapore to California and the closure of biologics units in Shanghai and in the Swiss town of Schlieren.

Advertisement

Related Content

Nothing Is Undruggable: Novartis' Bradner On CAR-T, CRISPR & DNA Libraries
Asia Attracts Manufacturing Capital As Companies Eye Expanding Needs
Novartis Cell Therapy Unit To Close: Implications For CAR-T Could Be Big
Novartis Rejiggers Pharma To Favor Oncology

Topics

Related Companies

Advertisement
UsernamePublicRestriction

Register

SC097432

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel